Divine Formulations Private Limited
About Divine Formulations Private Limited
Data last updated:
Divine Formulations Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Powercon Systems Pvt.Ltd.. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 15 February 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2000PTC191118. Its GSTIN is 05AACCD1429P2ZK (Uttarakhand). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹3.75 Cr and a paid-up capital of ₹3.74 Cr. It is led by directors Mukesh Kumar Tayal and Priyanka Tayal.
Its last annual general meeting (AGM) was held on 28 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.74 Cr. For the same year it recorded a net profit of ₹1.57 Cr (net margin 90.4%) and EBITDA of ₹1.74 Cr (EBITDA margin 99.8%). Revenue has grown at a compounded annual rate (CAGR) of 404% over three years.
As per MCA filings, the company has satisfied charges of ₹7.4 Cr on record. Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address44/45 1st Floor Juhu Supreme Shopping Centre Gulmohoor Road Jvpd Scheme Vile Parle, (West), Mumbai, Maharashtra, India – 400049
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Divine Formulations Private Limited FY 2024 filings available
Divine Formulations Private Limited reported revenue of ₹1.74 Cr for FY 2025.
Compounded Annual Growth Rate (CAGR) of Divine Formulations Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 404% over three years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Divine Formulations Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.74 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.57 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Divine Formulations Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 99.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 90.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Divine Formulations are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Divine Formulations Private Limited
Divine Formulations Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Universal Drug House Pvt Ltd | ₹1.75 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | Beleghata, West Bengal, India |
| Ultracare Remedies Private Limited | ₹1.75 Cr (FY 2025) | •••• | •••• | -16.0% | •••• | Rajkot, Gujarat, India |
| Oriental Pharmaceutical Industries Limited | ₹1.75 Cr (FY 2024) | •••• | •••• | 0.0% | •••• | Vishalgad, Maharashtra, India |
| Satellite Pharmaceuticals Private Limited | ₹1.74 Cr (FY 2025) | •••• | •••• | 18.0% | •••• | Mumbai, Maharashtra, India |
| Melius Healthcare Private Limited | ₹1.74 Cr (FY 2025) | •••• | •••• | 53.0% | •••• | Pune, Maharashtra, India |
| Divine Formulations Private Limited this company | ₹1.74 Cr (FY 2025) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Adam Laboratories Private Limited | ₹1.74 Cr (FY 2024) | •••• | •••• | 17.0% | •••• | Uttar Pradesh, India |
| Medicone Formulations Private Limited | ₹1.74 Cr (FY 2024) | •••• | •••• | 6.0% | •••• | New Delhi, Delhi, India |
| Sandmartin Pharmaceuticals Private Limited | ₹1.74 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | New Delhi, Delhi, India |
| Rex Medicare Private Limited | ₹1.73 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Ahmedabad, Gujarat, India |
| Decina Pharma Private Limited | ₹1.73 Cr (FY 2025) | •••• | •••• | -51.0% | •••• | Pune, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Divine Formulations by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Divine Formulations Private Limited
Divine Formulations Private Limited is audited by JHUNJHUNWALA JAIN & ASSOCIATES LLP for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| JHUNJHUNWALA JAIN & ASSOCIATES LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Divine Formulations Private Limited
Divine Formulations has 2 current directors and 15 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mukesh Kumar Tayal Also directs: Tayal Inorganic Private Limited, Digmore Autotech Private Limited | Director | 06 Jan 2024 | 2 Years 9 Months | Current |
| Priyanka Tayal Also directs: Tayal Inorganic Private Limited, Digmore Autotech Private Limited | Director | 07 Feb 2024 | 2 Years 8 Months | Current |
Ownership and Shareholding of Divine Formulations Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Divine Formulations Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Mar 2005 | State Bank of India | ₹7.35 Cr | Satisfied |
| 22 Dec 2003 | State Bank of India | ₹5 Lakh | Satisfied |
Total charge records: 2 View all charges
Legal Cases of Divine Formulations Private Limited
Divine Formulations Private Limited has 1 court case on record: 1 filed against it. All case is disposed. Status as checked on 02 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Haridwar, Uttarakhand | Criminal case | Filed against the company by an individual | Disposed |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Divine Formulations Private Limited
Employment history and EPFO contributions of people linked to Divine Formulations.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Divine Formulations Private Limited
Divine Formulations has one previous CIN (Corporate Identification Number): U24230GJ2000PTC037366. The current CIN is U24230MH2000PTC191118, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230MH2000PTC191118 | Current |
| U24230GJ2000PTC037366 | Previous |
Recent Activity on Divine Formulations Private Limited
Divine Formulations Private Limited has 17 board changes on record since 2007: 2 appointments and 15 cessations. The latest: Mukesh Kumar Tayal ceased to be Additional Director on 27 Sep 2024.
13 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Divine Formulations Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Divine Formulations Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Divine Formulations Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Divine Formulations Private Limited
Divine Formulations has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AACCD1429P2ZK | Uttarakhand | Active | 10 May 2024 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Divine Formulations Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Divine Formulations Private Limited
Divine Formulations is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 15 February 2000 (26+ years old) and is registered under CIN U24230MH2000PTC191118.
Divine Formulations reported revenue of ₹1.74 Cr for FY 2025.
Divine Formulations has 2 current directors:
- Mukesh Kumar Tayal - Director
- Priyanka Tayal - Director
Divine Formulations reported a net profit of ₹1.57 Cr (net margin 90.4%) and EBITDA of ₹1.74 Cr (EBITDA margin 99.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Divine Formulations is 404% over three years. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Divine Formulations is 05AACCD1429P2ZK, registered in Uttarakhand. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Divine Formulations is U24230MH2000PTC191118. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Divine Formulations has 1 court case on record: 1 filed against it.
Divine Formulations was incorporated on 15 February 2000, making it 26+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Divine Formulations by revenue are Universal Drug House Pvt Ltd, Ultracare Remedies Private Limited, Oriental Pharmaceutical Industries Limited, Satellite Pharmaceuticals Private Limited, Melius Healthcare Private Limited and 5 more, all in the Pharma industry (Formulations).
Mukesh Kumar Tayal ceased to be Additional Director on 27 Sep 2024. Priyanka Tayal ceased to be Additional Director on 27 Sep 2024. Priyanka Tayal was appointed as Director on 07 Feb 2024. Divine Formulations has 17 board changes on record in total.